Research Article
The Effects of Axitinib plus Tislelizumab in the Treatment of Advanced Renal Cell Carcinoma
Table 3
Adverse reactions between the two groups (n (%)).
| | Study group(n = 22) | Total | Control group (n = 27) | Total | | I | II | III | 60 | I | II | III | 54 |
| | Hypertension | 6 | 3 | 1 | 10 | 5 | 5 | 1 | 11 | | Hoarseness | 5 | 5 | 1 | 10 | 4 | 3 | 0 | 7 | | Hypothyroidism | 1 | 1 | 0 | 2 | 1 | 0 | 0 | 1 | | Anorexia | 3 | 2 | 0 | 5 | 3 | 3 | 0 | 6 | | Fatigue | 5 | 4 | 0 | 9 | 4 | 3 | 0 | 7 | | Diarrhea | 3 | 3 | 0 | 6 | 2 | 2 | 0 | 4 | | Hand-foot skin reaction | 4 | 2 | 0 | 6 | 3 | 1 | 0 | 4 | | Immune associated pneumonia | 2 | 1 | 0 | 3 | 2 | 1 | 0 | 3 | | Vomiting | 5 | 4 | 0 | 9 | 6 | 5 | 0 | 11 |
|
|
